Prenatal diagnosis
Once an Epidermolysis Bullosa
(EB) diagnosis has been confirmed by skin biopsy and molecular genetic studies
(DNA analysis) prenatal diagnosis of future pregnancies becomes possible. DNA
for prenatal diagnosis can be obtained as a chorionic villi sample as early as
the 9th week of gestation. Alternatively, amniotic fluid
drawn after the 11th week can provide the necessary DNA.
Following steps are
required for prenatal diagnosis of EB:
1.
Biopsy
diagnosis of an affected family member is needed to identify EB
subtype.
2.
After
subtype is identified, DNA sample is sent to lab for identification of the
genetic mutation.
3.
After
genetic mutation is identified, amniotic fluid or chorionic villus sampling (CVS)
is obtained during pregnancy which is sent to the genetic laboratory and
evaluated for the previously identified mutation. Placental cells may be
obtained through a CVS, performed at approximately 10-12 weeks gestation, and
amniotic fluid may be obtained through amniocentesis, at approximately 15-18
weeks gestation.
Many EB parents prefer
to have prenatal diagnosis completed utilizing CVS rather than amniocentesis.
Preimplantation genetic
diagnosis (PGD) improves the likelihood of an EB-free birth. PGD is
accomplished by genetic analysis of a fertilized egg before implantation with
the following step:
1.
DNA
analysis is performed to identify the genetic mutation present
in the affected person.
2.
Hormone
injections to the prospective mother to stimulate her ovaries for development
of eggs.
3.
The
eggs are retrieved from the mother and fertilized with the father’s sperm,
usually by a reproductive endocrinology (in vitro fertilization).
4.
When
the fertilized egg has developed into at least eight cells, one cell is removed
and analyzed in the laboratory to determine whether it carries the genetic
mutation present in the affected person.
5.
If
the mutation is not detected, the fertilized eggs are implanted in the mother’s
womb in anticipation of the birth of a child who does not have EB.
This
procedure has resulted in successful outcomes for many EB families but it is
expensive.
No comments:
Post a Comment